Compare CLBK & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CLBK | TLRY |
|---|---|---|
| Founded | 1927 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 919.2M |
| IPO Year | 2017 | 2018 |
| Metric | CLBK | TLRY |
|---|---|---|
| Price | $18.29 | $7.59 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 4 |
| Target Price | $17.00 | ★ $103.33 |
| AVG Volume (30 Days) | 314.1K | ★ 2.5M |
| Earning Date | 05-04-2026 | 04-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.35 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $3.97 | $7.39 |
| Revenue Next Year | $11.43 | $4.76 |
| P/E Ratio | $51.20 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $12.64 | $0.36 |
| 52 Week High | $18.87 | $15.70 |
| Indicator | CLBK | TLRY |
|---|---|---|
| Relative Strength Index (RSI) | 60.13 | 44.80 |
| Support Level | $17.82 | $7.11 |
| Resistance Level | $18.77 | $8.31 |
| Average True Range (ATR) | 0.48 | 0.39 |
| MACD | -0.08 | 0.05 |
| Stochastic Oscillator | 70.18 | 31.43 |
Columbia Financial Inc is a federally chartered savings bank that serves the financial needs of depositors and the local community as a community-minded, customer service-focused institution. It offers traditional financial services to businesses and consumers. It attracts deposits from the general public and uses those funds to originate a variety of loans, including multifamily and commercial real estate loans, commercial business loans, one-to-four family real estate loans, construction loans, home equity loans and advances, and other consumer loans, and also offers a broad range of insurance products, investment solutions, and wealth management services.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.